Johnson & Johnson (BSP:JNJB34)
R$ 60.12 0 (0%) Market Cap: 2.18 Til Enterprise Value: 2.27 Til PE Ratio: 24.52 PB Ratio: 5.08 GF Score: 76/100

Johnson & Johnson at Citi Healthcare Conference (Virtual) Transcript

Feb 23, 2022 / 04:00PM GMT
Release Date Price: R$53.41 (-1.31%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Well, everybody, thank you for joining us for the next session of the Citi Healthcare Conference. This one, I'm very pleased to have with us, Ashley McEvoy from Johnson & Johnson. Ashley, thank you for joining us this morning.

Ashley A. McEvoy
Johnson & Johnson - Executive VP & Worldwide Chairman of Med Tech

Joanne, it's a pleasure to see you. Although I'm not there live with you, but I'm looking forward to that time. Thanks for having me.

Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Me too. Enough of the virtual stuff.

Ashley A. McEvoy
Johnson & Johnson - Executive VP & Worldwide Chairman of Med Tech

Yes.

Questions & Answers

Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Anyway, I do have to ask about what you're seeing in the current backdrop of procedures, because as earnings cycle has moved on, we're

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot